Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
38
NCT05562206
CGMIS 48-hour Feasibility Study
Phase: N/A
Role: Lead Sponsor
Start: Aug 30, 2022
Completion: Nov 30, 2022
NCT05185518
Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes
Start: Sep 30, 2025
Completion: Feb 28, 2026